# An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery

> **NCT03011320** · PHASE1 · COMPLETED · sponsor: **Endocyte** · enrollment: 3 (actual)

## Conditions studied

- Ovary Cancer

## Interventions

- **DRUG:** EC1456
- **DRUG:** 99mTc-Etarfolatide

## Key facts

- **NCT ID:** NCT03011320
- **Lead sponsor:** Endocyte
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-24
- **Primary completion:** 2017-12-30
- **Final completion:** 2018-08-28
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2019-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03011320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03011320, "An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03011320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*